MENU
VKTX
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Viking Therapeutics (VKTX) Ownership - Who owns Viking Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
9920 Pacific Heights Boulevard
Phone
+1 858 704-4660
Employees
27
Web
https://www.vikingtherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.02B
P/E Ratio
N/A
Total Cash
942.26M
Projected Growth
N/A
Total Debt
1.1M
Revenue
N/A
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash/Share
8.50
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
VKTX
Capitalization
7.02B
P/E Ratio
N/A
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash
942M
Total Cash/Share
8.50
Total Debt
1.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
921M
P/B Ratio
7.62
Cash Flow
N/A
Earnings
-0.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
37.69
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-124.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.36
Shares Held By Institutions
16.2B
Shares Outstanding - Current
111M
Total Liabilities
25.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
253.842
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company that engages in the development of therapies for metabolic and endocrine disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9920 Pacific Heights Boulevard
Phone
+1 858 704-4660
Employees
27
Web
https://www.vikingtherapeutics.com